Gamgee Technologies operates an AI-first genomics platform that designs personalised mRNA cancer vaccines, initially focused on canine patients.
The company integrates tumor sequencing, computational target selection, patient-specific manufacturing, and clinical outcome data into a closed learning loop to iteratively improve treatment selection and vaccine design.
Leadership & Board
Key Executives
FounderPaul Steven Conyngham
Current Number of Employees4
Current LinkedIn Followers1,363
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Gamgee Technologies (YC S26) had 4 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
4Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Gamgee Technologies (YC S26) had 1,363 followers as of September 28, 2026. The number of followers increased by 22 (1.64%) week-over-week.
1,363Latest Followers Count
22(1.64%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 21, 2026
Seed Round
$4.00M
―
Similar Companies
A snapshot of private companies similar to Gamgee Technologies (YC S26), helping you discover and navigate related company profiles.